Figure S2 from Preclinical Evaluation of a Cabazitaxel Prodrug Using Nanoparticle Delivery for the Treatment of Taxane-Resistant Malignancies

作者：Binbin Xie, Jianqin Wan, Xiaona Chen, Weidong Han, Hangxiang Wang · 年份：2023 · DOI：10.1158/1535-7163.22518730 · 研究领域：Nanoparticle-Based Drug Delivery、Cancer Treatment and Pharmacology、Metal complexes synthesis and properties

<p>Supplementary Figure S2. The cytotoxicity of dCTX NPs compared with cabazitaxel against cancer cell lines in vitro. Analysis (A) and quantification (B) of apoptosis of HeLa and A549 cells after the treatment with dCTX NPs for 48 h. The drug concentrations used to treat HeLa and A549 cells were 16 and 4 nM, respectively.</p>